A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus

Hiromasa Kobayashi, I. Fujisawa, K. Ikeda, C. Son, T. Iwakura, A. Yoshimoto, M. Kasahara, T. Ishihara, Y. Ogawa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The autosomal dominant familial neuronal diabetes insipidus (adFNDI) is caused by diverse mutations in one allele of the gene that encodes the arginine vasopressin (AVP) precursor protein, AVP-neurophysin II (AVP-NP II). Most of the mutations identified so far are located in either the signal peptide or NP II moiety. Two recently published mutations in the AVP gene identified in kindreds with adFNDI predict a substitution of histidine for tyrosine at position 2 and a deletion of phenylalanine at position 3 in AVP. They are unique among adFNDI mutations in that they are the only adFNDI mutations that affect amino acid residues in the AVP moiety of the pro-hormone. Here, we report a novel heterozygous missense mutation in the AVP moiety of the AVP-NP II gene in a Japanese person with neurohypophyseal diabetes insipidus (DI). This mutation occurs at position 2 in AVP and predicts a substitution of serine for tyrosine (Y21S). It is expected to interfere with normal binding of AVP with NP II, and thus result in misfolding of the precursor proteins. The data of this study support the notion that mutations affecting the AVP moiety can result in the initiation of the pathological processes.

Original languageEnglish
Pages (from-to)252-256
Number of pages5
JournalJournal of Endocrinological Investigation
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Neurogenic Diabetes Insipidus
Arginine Vasopressin
Missense Mutation
Vasopressins
Diabetes Insipidus
Mutation
Protein Precursors
Tyrosine
Neurophysins
Genes
Pathologic Processes
Protein Sorting Signals
Phenylalanine
Histidine
Serine
Alleles

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus. / Kobayashi, Hiromasa; Fujisawa, I.; Ikeda, K.; Son, C.; Iwakura, T.; Yoshimoto, A.; Kasahara, M.; Ishihara, T.; Ogawa, Y.

In: Journal of Endocrinological Investigation, Vol. 29, No. 3, 03.2006, p. 252-256.

Research output: Contribution to journalArticle

Kobayashi, Hiromasa ; Fujisawa, I. ; Ikeda, K. ; Son, C. ; Iwakura, T. ; Yoshimoto, A. ; Kasahara, M. ; Ishihara, T. ; Ogawa, Y. / A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus. In: Journal of Endocrinological Investigation. 2006 ; Vol. 29, No. 3. pp. 252-256.
@article{05e9fc50e64e4d9a9ace618189cd5ec3,
title = "A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus",
abstract = "The autosomal dominant familial neuronal diabetes insipidus (adFNDI) is caused by diverse mutations in one allele of the gene that encodes the arginine vasopressin (AVP) precursor protein, AVP-neurophysin II (AVP-NP II). Most of the mutations identified so far are located in either the signal peptide or NP II moiety. Two recently published mutations in the AVP gene identified in kindreds with adFNDI predict a substitution of histidine for tyrosine at position 2 and a deletion of phenylalanine at position 3 in AVP. They are unique among adFNDI mutations in that they are the only adFNDI mutations that affect amino acid residues in the AVP moiety of the pro-hormone. Here, we report a novel heterozygous missense mutation in the AVP moiety of the AVP-NP II gene in a Japanese person with neurohypophyseal diabetes insipidus (DI). This mutation occurs at position 2 in AVP and predicts a substitution of serine for tyrosine (Y21S). It is expected to interfere with normal binding of AVP with NP II, and thus result in misfolding of the precursor proteins. The data of this study support the notion that mutations affecting the AVP moiety can result in the initiation of the pathological processes.",
author = "Hiromasa Kobayashi and I. Fujisawa and K. Ikeda and C. Son and T. Iwakura and A. Yoshimoto and M. Kasahara and T. Ishihara and Y. Ogawa",
year = "2006",
month = "3",
doi = "10.1007/BF03345549",
language = "English",
volume = "29",
pages = "252--256",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "3",

}

TY - JOUR

T1 - A novel heterozygous missense mutation in the vasopressin moiety is identified in a Japanese person with neurohypophyseal diabetes insipidus

AU - Kobayashi, Hiromasa

AU - Fujisawa, I.

AU - Ikeda, K.

AU - Son, C.

AU - Iwakura, T.

AU - Yoshimoto, A.

AU - Kasahara, M.

AU - Ishihara, T.

AU - Ogawa, Y.

PY - 2006/3

Y1 - 2006/3

N2 - The autosomal dominant familial neuronal diabetes insipidus (adFNDI) is caused by diverse mutations in one allele of the gene that encodes the arginine vasopressin (AVP) precursor protein, AVP-neurophysin II (AVP-NP II). Most of the mutations identified so far are located in either the signal peptide or NP II moiety. Two recently published mutations in the AVP gene identified in kindreds with adFNDI predict a substitution of histidine for tyrosine at position 2 and a deletion of phenylalanine at position 3 in AVP. They are unique among adFNDI mutations in that they are the only adFNDI mutations that affect amino acid residues in the AVP moiety of the pro-hormone. Here, we report a novel heterozygous missense mutation in the AVP moiety of the AVP-NP II gene in a Japanese person with neurohypophyseal diabetes insipidus (DI). This mutation occurs at position 2 in AVP and predicts a substitution of serine for tyrosine (Y21S). It is expected to interfere with normal binding of AVP with NP II, and thus result in misfolding of the precursor proteins. The data of this study support the notion that mutations affecting the AVP moiety can result in the initiation of the pathological processes.

AB - The autosomal dominant familial neuronal diabetes insipidus (adFNDI) is caused by diverse mutations in one allele of the gene that encodes the arginine vasopressin (AVP) precursor protein, AVP-neurophysin II (AVP-NP II). Most of the mutations identified so far are located in either the signal peptide or NP II moiety. Two recently published mutations in the AVP gene identified in kindreds with adFNDI predict a substitution of histidine for tyrosine at position 2 and a deletion of phenylalanine at position 3 in AVP. They are unique among adFNDI mutations in that they are the only adFNDI mutations that affect amino acid residues in the AVP moiety of the pro-hormone. Here, we report a novel heterozygous missense mutation in the AVP moiety of the AVP-NP II gene in a Japanese person with neurohypophyseal diabetes insipidus (DI). This mutation occurs at position 2 in AVP and predicts a substitution of serine for tyrosine (Y21S). It is expected to interfere with normal binding of AVP with NP II, and thus result in misfolding of the precursor proteins. The data of this study support the notion that mutations affecting the AVP moiety can result in the initiation of the pathological processes.

UR - http://www.scopus.com/inward/record.url?scp=33646249391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646249391&partnerID=8YFLogxK

U2 - 10.1007/BF03345549

DO - 10.1007/BF03345549

M3 - Article

C2 - 16682840

AN - SCOPUS:33646249391

VL - 29

SP - 252

EP - 256

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -